Kendall Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,115
| Closed | -$119K | – | 186 |
|
|
2022
Q4 | $119K | Sell |
10,115
-1,280
| -11% | -$15.1K | 0.06% | 179 |
|
|
2022
Q3 | $239K | Hold |
11,395
| – | – | 0.14% | 149 |
|
|
2022
Q2 | $354K | Sell |
11,395
-190
| -2% | -$5.9K | 0.2% | 128 |
|
|
2022
Q1 | $476K | Buy |
11,585
+525
| +5% | +$21.6K | 0.23% | 113 |
|
|
2021
Q4 | $481K | Buy |
11,060
+3,055
| +38% | +$133K | 0.23% | 110 |
|
|
2021
Q3 | $401K | Buy |
8,005
+3,610
| +82% | +$181K | 0.22% | 108 |
|
|
2021
Q2 | $277K | Buy |
+4,395
| New | +$277K | 0.16% | 132 |
|